FUREN Group Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 641.04 million compared to CNY 878.42 million a year ago. Revenue was CNY 690.42 million compared to CNY 902.26 million a year ago.

Net loss was CNY 411.77 million compared to CNY 294.25 million a year ago. Basic loss per share from continuing operations was CNY 0.66 compared to CNY 0.47 a year ago. Diluted loss per share from continuing operations was CNY 0.66 compared to CNY 0.47 a year ago.